Caris Life Sciences Announces Planned Expansion of Next-Generation Sequencing (NGS) Capabilities ; Supplementary Genomic Analysis Will Offer Complement to Best-in-Class Molecular Profiling Clinical Tool

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Source:
    PR Newswire (USA), May 31, 2013, 2pp
  • Additional Information
    • Abstract:
      IRVING, Texas, May 31, 2013 /PRNewswire/ -- Caris Life Sciences™, a leading biosciences company focused on fulfilling the promise of personalized medicine, today announced it intends to expand its Next-Generation Sequencing (NGS) capabilities to include whole exome and transcriptome sequencing. The offering will provide physicians with an in-depth report focusing on the 452 well-documented somatic alterations present across all cancer types...